Invention Grant
- Patent Title: Transdermal drug delivery system containing donepezil
-
Application No.: US14627899Application Date: 2015-02-20
-
Publication No.: US10195408B2Publication Date: 2019-02-05
- Inventor: Y. Joseph Mo , Tiffany Kawai
- Applicant: NAL PHARMACEUTICAL GROUP LIMITED
- Applicant Address: HK Causeway Bay
- Assignee: NAL PHARMACEUTICAL GROUP LIMITED
- Current Assignee: NAL PHARMACEUTICAL GROUP LIMITED
- Current Assignee Address: HK Causeway Bay
- Agency: Lucas & Mercanti, LLP
- Main IPC: A61M35/00
- IPC: A61M35/00 ; A61K31/445 ; A61K9/70

Abstract:
Certain embodiments of the invention relates to a transdermal drug delivery system containing donepezil or a pharmaceutically acceptable salt thereof as an active ingredient, more specifically to a transdermal drug delivery system containing a drug-containing matrix layer comprising donepezil or its pharmaceutically acceptable salt, a styrene copolymer, a hydrogenated rosin glycerol ester, and optionally a hydrocarbon resin.
Public/Granted literature
- US20150258036A1 TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING DONEPEZIL Public/Granted day:2015-09-17
Information query
IPC分类: